Genetic disruption of dopamine production results in pituitary adenomas and severe prolactinemia

Neuroendocrinology

Volumn 86, Issue 1, 2007, Pages 48-57

  Hnasko, Thomas S ^a   Hnasko, Robert M ^c   Sotak, Bethany N ^b   Kapur, Raj P ^a   Palmiter, Richard D ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c WESTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

Canine adenovirus; Dopamine deficiency; Lactotroph; Pituitary; Prolactin; Prolactinoma; Tuberoinfundibular; Viral gene transfer

Indexed keywords

DOPAMINE; LEVODOPA; PROLACTIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE DEFICIENT MOUSE; DOPAMINE METABOLISM; DOPAMINE RELEASE; FEMALE; GENETIC MODEL; GROWTH HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HYPERTROPHY; HYPOPHYSIS ADENOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; SEMINAL VESICLE; VIRAL GENE DELIVERY SYSTEM;

ADENOMA; ANIMALS; DOPAMINE; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PITUITARY NEOPLASMS; PROLACTIN;

EID: 34547623374     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000105242     Document Type: Article

References (29)

1. Ben-Jonathan N, Hnasko R: Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 2001;22:724-763.
2. Hyde JF, Ben-Jonathan N: Characterization of prolactin-releasing factor in the rat posterior pituitary. Endocrinology 1988;122:2533-2539.
3. Kelly MA, Rubinstein M, Asa SL, Zhang G, Saez C, Bunzow JR, Allen RG, Hnasko R, Ben-Jonathan N, Grandy DK, Low MJ: Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 1997;19:103-113.
4. Saiardi A, Bozzi Y, Baik JH, Borrelli E: Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron 1997;19:115-126.
5. Zhou QY, Palmiter RD: Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 1995;83:1197-1209.
6. Hnasko TS, Perez FA, Scouras AD, Stoll EA, Gale SD, Luquet S, Phillips PE, Kremer EJ, Palmiter RD: Cre recombinase-mediated restoration of nigrostriatal dopamine in dopamine-deficient mice reverses hypophagia and bradykinesia. Proc Natl Acad Sci USA 2006;103:8858-8863.
7. Kremer EJ, Boutin S, Chillon M, Danos O: Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J Virol 2000;74:505-512.
8. Szczypka MS, Kwok K, Brot MD, Marck BT, Matsumoto AM, Donahue BA, Palmiter RD: Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice. Neuron 2001;30:819-828.
9. Carson FL: Histotechnology: A Self-Instructional Text, ed 2. Chicago, ASCP Press, 1997.
10. Soudais C, Skander N, Kremer EJ: Long-term in vivo transduction of neurons throughout the rat CNS using novel helper-dependent CAV-2 vectors. FASEB J 2004;18:391-393.
11. Diaz-Torga G, Feierstein C, Libertun C, Gelman D, Kelly MA, Low MJ, Rubinstein M, Becu-Villalobos D: Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice. Endocrinology 2002;143:1270-1279.
12. Schuff KG, Hentges ST, Kelly MA, Binart N, Kelly PA, Iuvone PM, Asa SL, Low MJ: Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest 2002;110:973-981.
13. Asa SL, Kelly MA, Grandy DK, Low MJ: Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology 1999;140:5348-5355.
14. Hentges ST, Low MJ: Ovarian dependence for pituitary tumorigenesis in D2 dopamine receptor-deficient mice. Endocrinology 2002;143:4536-4543.
15. Freeman ME, Kanyicska B, Lerant A, Nagy G: Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000;80:1523-1631.
16. Perez RL, Machiavelli GA, Romano MI, Burdman JA: Prolactin release, oestrogens and proliferation of prolactin-secreting cells in the anterior pituitary gland of adult male rats. J Endocrinol 1986;108:399-403.
17. de la Torre NG, Turner HE, Wass JA: Angiogenesis in prolactinomas: regulation and relationship with tumour behaviour. Pituitary 2005;8:17-23.
18. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S: Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 1999;5:1317-1321.
19. Saiardi A, Borrelli E: Absence of dopaminergic control on melanotrophs leads to Cushing's-like syndrome in mice. Mol Endocrinol 1998;12:1133-1139.
20. Bosse R, Fumagalli F, Jaber M, Giros B, Gainetdinov RR, Wetsel WC, Missale C, Caron MG: Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 1997;19:127-138.
21. Ouhtit A, Morel G, Kelly PA: Visualization of gene expression of short and long forms of prolactin receptor in the rat. Endocrinology 1993;133:135-144.
22. Steger RW, Chandrashekar V, Zhao W, Bartke A, Horseman ND: Neuroendocrine and reproductive functions in male mice with targeted disruption of the prolactin gene. Endocrinology 1998;139:3691-3695.
23. Debeljuk L, Steger RW, Wright JC, Mattison J, Bartke A: Effects of overexpression of growth hormone-releasing hormone on the hypothalamo-pituitary- gonadal function in the mouse. Endocrine 1999;11:171-179.
24. Tascou S, Trappe R, Nayernia K, Jarry H, Konig F, Schulz-Schaeffer W, Saeger W, Meinhardt A, Engel W, Schmidtke J, Burfeind P: TSPY-LTA transgenic mice develop endocrine tumors of the pituitary and adrenal gland. Mol Cell Endocrinol 2003;200:9-18.
25. Obal F Jr, Garcia-Garcia F, Kacsoh B, Taishi P, Bohnet S, Horseman ND, Krueger JM: Rapid eye movement sleep is reduced in prolactin-deficient mice. J Neurosci 2005;25:10282-10289.
26. Freemark M, Fleenor D, Driscoll P, Binart N, Kelly P: Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology 2001;142:532-537.
27. Freemark M, Avril I, Fleenor D, Driscoll P, Petro A, Opara E, Kendall W, Oden J, Bridges S, Binart N, Breant B, Kelly PA: Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. Endocrinology 2002;143:1378-1385.
28. Gerardo-Gettens T, Moore BJ, Stern JS, Horwitz BA: Prolactin stimulates food intake in a dose-dependent manner. Am J Physiol 1989;256:R276-R280.
29. Hnasko RM, Buntin JD: Functional mapping of neural sites mediating prolactin-induced hyperphagia in doves. Brain Res 1993;623:257-266.